我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
100.0%
暂无批准数据
- Treace Medical Concepts presented interim data from three clinical studies at the ACFAS 2026 conference, demonstrating positive outcomes for their bunion correction technologies. - The ALIGN3D study showed 8.4% radiographic recurrence rates at 48 months and 95% lower recurrence risk in patients with proper 3D correction. - The company unveiled six new product innovations including SpeedTMT rapid compression implants and Lightning instrumentation system for enhanced surgical precision. - Clinical data demonstrated early weight-bearing recovery averaging 3.7-8.4 days across different procedures with maintained correction through 24 months.